Alto Neuroscience (ANRO) has announced it possesses sufficient financial resources to fund its planned operations. This funding runway extends through the year 2029, providing long-term stability.
Alto Neuroscience Secures Funding Runway Through 2029
biotechfundingfinancial-outlookANROhealthcare



